Page 50 - Jurnal Farmasi Klinik Vol 4 No 1

Jurnal Farmasi Klinik Best Practice Volume 4 No 1

Randomized Clinical 52. Liu D, Ahmet A, Ward L,

Trial. JAMA. 2017;318(5):432– Krishnamoorthy P, Mandelcorn

442. ED, Leigh R, dkk. A pratical
doi:10.1001/jama.2017.9362 guide to the monitoring and

46. Remick DG. Pathophysiology of management of the
sepsis. Am J Pathol. complications of systemic

2007;170(5):1435–44. doi: corticosteroid therapy. Allergy

10.2353/ajpath.2007.060872. Asthma Clin Immunol.
47. Youssef J, Novosad SA, 2013;9:1-25. doi:10.1186/1710-

Winthrop KL. Infection Risk 1492-9-20.
and Safety of Corticosteroid Use. 53. Klein NC, Go CH, Cunha BA.

Rheum Dis Clin North Am. Infections associated with

2016 Feb;42(1):157-76, ix-x. doi: steroid use. Infect Dis Clin
10.1016/j.rdc.2015.08.004. Epub North Am. 2001 Jun;15(2):423

2015 Oct 24. PMID: 26611557; 32, viii. doi: 10.1016/s0891
PMCID: PMC4751577. 5520(05)70154-9. PMID:

48. Go CHU, Cunha BA Infections 11447704.
in patients on steroids. Infectious 54. Touma Z, Urowitz MB.

Disease Practice 2461, 2000. Systemic Glucocorticoids. In:

49. Fauman AG. An overview of the Tsokos GC, editor. Systemic
adverse reaction to adrenal Lupus Erythematosus Basic,

corticosteroids. Adverse Drug Applied, and Clinical Aspects.
React Toxic 01 Rev 15203,1996. Oxford: Elsevier; 2016. P. 521-

50. Lefering R, Neugebauer EA: 31.

Steroids controversy in sepsis 55. Kirou KA, Boumpas DT.
and septic shock A meta- Systemic glucocorticoid therapy.

analysis. Crit Care Med 231294, In: Wallace DJ, Hahn BH,
1995. editors. Dubois’ lupus

51. Zoorob RJ, Cender D A different erythematosus and related

look at corticosteroids. Am Fam syndromes. 8th ed. Philadelphia:
Physician 58443, 1998. Elsevier Saunders; 2013. p. 591-

600.

https://jfklin.rsupfatmawati.co.id/jfklin 49